Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<1
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
00-6
EC/CAS
215-279-6
Name of the chemical
Calcium carbonate
Concentration
25 - 50
EC/CAS
247-500-7
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one
Concentration
<1
EC/CAS
220-239-6
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one 2-Methyl-2H-isothiazol-3-one
Concentration
00-5
General Information
Version
1.2
Revision date
2024-12-23
Product name
ReduSol
1.2.1 Relevant identified uses
Industrial/Professional use spec Industrial
Manufacturer Name
Lumiforte EMEA B.V
Emergency telephone
+44 20 7188 7188
Icons in SDS
Company Information
company name
Lumiforte EMEA B.V
e-mail address of the competent person responsible for the Safety Data Sheet
safety@lumiforte.com
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Supplemental label elements
EUH208 - Contains Mixture of: 5-chloro-2-methyl-4-isothiazolin-3-one [N. CE 247-500-7] and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1) (55965- 84-9), 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one (2634-33-5). May produce an allergic reaction. EUH210 - Safety data sheet available on request.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Mixture of: 5-chloro-2-methyl-4-isothiazolin-3- The mixture does not contain substance(s) included in the list established in one [N. CE 247-500-7] and 2-methyl-2H - accordance with Article 59(1) of REACH for having endocrine disrupting isothiazol-3-one [EC no. 220-239-6] properties, or is not identified as having endocrine disrupting properties in (3:1)(55965-84-9) accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects No additional information available 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP]
